CXCL12 and cardiac hypertrophy: As shown in Figure 8B,C, SM-CXCL12−/− mice treated with TC14012 showed significantly reduced interventricular septum (IVSD) and left ventricular posterior wall diameters (LVPWD) reflecting attenuated progression of cardiac hypertrophy.